- Home
- TRAK vs RCKT Comparison
TRAK vs RCKT Comparison
Compare TRAK & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRAK
- RCKT
- Stock Information
- Founded
- TRAK 1990
- RCKT 1999
- Country
- TRAK United States
- RCKT United States
- Employees
- TRAK N/A
- RCKT N/A
- Industry
- TRAK EDP Services
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- TRAK Technology
- RCKT Health Care
- Exchange
- TRAK Nasdaq
- RCKT Nasdaq
- Market Cap
- TRAK 274.4M
- RCKT 328.6M
- IPO Year
- TRAK 1998
- RCKT N/A
- Fundamental
- Price
- TRAK $15.01
- RCKT $3.77
- Analyst Decision
- TRAK
- RCKT Buy
- Analyst Count
- TRAK 0
- RCKT 13
- Target Price
- TRAK N/A
- RCKT $12.88
- AVG Volume (30 Days)
- TRAK 62.7K
- RCKT 2.9M
- Earning Date
- TRAK 11-13-2025
- RCKT 11-03-2025
- Dividend Yield
- TRAK 0.53%
- RCKT N/A
- EPS Growth
- TRAK 20.69
- RCKT N/A
- EPS
- TRAK 0.35
- RCKT N/A
- Revenue
- TRAK $22,606,066.00
- RCKT N/A
- Revenue This Year
- TRAK $12.20
- RCKT N/A
- Revenue Next Year
- TRAK $20.00
- RCKT $3,582.16
- P/E Ratio
- TRAK $42.89
- RCKT N/A
- Revenue Growth
- TRAK 10.53
- RCKT N/A
- 52 Week Low
- TRAK $13.87
- RCKT $2.19
- 52 Week High
- TRAK $25.01
- RCKT $18.17
- Technical
- Relative Strength Index (RSI)
- TRAK 45.41
- RCKT 52.95
- Support Level
- TRAK $14.35
- RCKT $3.67
- Resistance Level
- TRAK $15.80
- RCKT $4.06
- Average True Range (ATR)
- TRAK 0.50
- RCKT 0.26
- MACD
- TRAK 0.09
- RCKT -0.03
- Stochastic Oscillator
- TRAK 54.07
- RCKT 15.92
About TRAK ReposiTrak Inc.
ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.